JP2021533796A5 - - Google Patents
Info
- Publication number
- JP2021533796A5 JP2021533796A5 JP2021509746A JP2021509746A JP2021533796A5 JP 2021533796 A5 JP2021533796 A5 JP 2021533796A5 JP 2021509746 A JP2021509746 A JP 2021509746A JP 2021509746 A JP2021509746 A JP 2021509746A JP 2021533796 A5 JP2021533796 A5 JP 2021533796A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr2
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862720708P | 2018-08-21 | 2018-08-21 | |
| US62/720,708 | 2018-08-21 | ||
| PCT/US2019/047250 WO2020041300A1 (en) | 2018-08-21 | 2019-08-20 | B7-h7-binding agents and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533796A JP2021533796A (ja) | 2021-12-09 |
| JP2021533796A5 true JP2021533796A5 (https=) | 2022-08-29 |
Family
ID=67841214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509746A Pending JP2021533796A (ja) | 2018-08-21 | 2019-08-20 | Ｂ７−ｈ７結合剤及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210198366A1 (https=) |
| EP (1) | EP3850009A1 (https=) |
| JP (1) | JP2021533796A (https=) |
| CN (1) | CN112930357A (https=) |
| AU (1) | AU2019326438A1 (https=) |
| CA (1) | CA3108905A1 (https=) |
| WO (1) | WO2020041300A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110760483B (zh) * | 2019-11-08 | 2021-06-22 | 扬州大学 | 具牛、羊交叉反应的抗TNF-α单克隆抗体的制备及应用 |
| CN118804927A (zh) * | 2022-01-21 | 2024-10-18 | 和铂医药(上海)有限责任公司 | 抗b7-h7抗体或其抗原结合片段及制备方法和应用 |
| WO2023173393A1 (zh) * | 2022-03-18 | 2023-09-21 | 北京天广实生物技术股份有限公司 | 结合b7-h3的抗体及其用途 |
| CN121773134A (zh) * | 2023-08-23 | 2026-03-31 | 南京再明医药有限公司 | B7-h7抗原结合分子及其应用 |
| CN119841949A (zh) * | 2023-10-17 | 2025-04-18 | 科辉智药(深圳)新药研究中心有限公司 | 一种抗人hhla2的纳米抗体及其应用 |
| WO2025111382A2 (en) * | 2023-11-21 | 2025-05-30 | Board Of Regents, The University Of Texas System | Anti-lamp5 antibodies, engineered immune cells expressing anti-lamp5 antibodies, and uses thereof |
| WO2025175056A1 (en) * | 2024-02-15 | 2025-08-21 | Nextpoint Therapeutics, Inc. | Multispecific antibodies or antigen binding fragments thereof to b7-h7 and immune effector cell antigens |
| CN121005781A (zh) * | 2024-05-24 | 2025-11-25 | 合肥天港免疫药物有限公司 | 高亲和力b7h7抗体或其抗原结合片段及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2769822C (en) * | 2009-08-13 | 2019-02-19 | The Johns Hopkins University | Methods of modulating immune function |
| US10093737B2 (en) * | 2013-03-01 | 2018-10-09 | Albert Einstein College Of Medicine, Inc. | HHLA2 as a novel inhibitor of human immune system and uses thereof |
| WO2015187359A1 (en) * | 2014-06-04 | 2015-12-10 | Ngm Biopharmaceuticals, Inc. | Compositions and methods for targeting a pathway |
-
2019
- 2019-08-20 WO PCT/US2019/047250 patent/WO2020041300A1/en not_active Ceased
- 2019-08-20 CN CN201980067874.XA patent/CN112930357A/zh active Pending
- 2019-08-20 US US17/269,635 patent/US20210198366A1/en not_active Abandoned
- 2019-08-20 AU AU2019326438A patent/AU2019326438A1/en not_active Abandoned
- 2019-08-20 EP EP19762577.5A patent/EP3850009A1/en not_active Withdrawn
- 2019-08-20 JP JP2021509746A patent/JP2021533796A/ja active Pending
- 2019-08-20 CA CA3108905A patent/CA3108905A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533796A5 (https=) | ||
| RU2018114523A (ru) | Анти-tigit антитела и способы применения | |
| JP2021508469A5 (https=) | ||
| JP2025032324A (ja) | 新規ｃｄ４０結合抗体 | |
| JP2021515565A5 (https=) | ||
| JP2021533726A5 (https=) | ||
| JP2021515568A5 (https=) | ||
| JP2019524693A5 (https=) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| JP2018532383A5 (https=) | ||
| JP2021516973A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2019535250A5 (https=) | ||
| CN116396386A (zh) | Cd3抗体及其药物用途 | |
| JP2019536470A5 (https=) | ||
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| RU2017118225A (ru) | Антитела к PD-1 и способы их применения | |
| JP2018517431A5 (https=) | ||
| JP2018503365A5 (https=) | ||
| JP2016505556A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2020522473A5 (https=) | ||
| RU2018126297A (ru) | Антитела, нацеленные на cd32b, и способы их применения | |
| JP2021520201A5 (https=) | ||
| JP2020502233A5 (https=) |